Taylor Carolyn E. 4

What Happened
Carolyn E. Taylor, a director of Tonix Pharmaceuticals Holding Corp. (TNXP), acquired 1,415 shares on June 12, 2026 via a purchase transaction (code P). The shares were bought at $10.55 per share for a total reported purchase value of $14,928. This was a direct purchase (indicated as open-market/private purchase) rather than a sale or option exercise.

Key Details

• Transaction date: 2026-06-12
• Price per share: $10.55
• Shares acquired: 1,415
• Total reported value: $14,928
• Transaction code: P (purchase); filing type: Form 4 filed 2026-06-15 (reports the June 12 transaction)
• Shares owned after transaction: not specified in the filing (not disclosed)
• Footnotes/plan disclosures: none reported (no 10b5-1 plan, tax withholding, or other notes in the filing)

Context
Insider purchases are often viewed as a more informative signal than routine sales because they represent the insider putting personal capital into the company; however, no motive can be inferred from the filing alone. This is a relatively small-dollar insider buy. Investors should combine this record with other company news and financials before drawing conclusions.